Sfoglia per AUTORE
CASTRO FL
Collezione AOU Alessandria

  

Items : 3

The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability. in Cephalalgia : an international journal of headache / Cephalalgia. 2026 Mar;46(3):3331024261416490. doi: 10.1177/03331024261416490. Epub 2026 Mar 25.
2026
AOU Alessandria

Rufa A; Ferrandi D; Pistoia F; Lanni C; Vaghi G; Doretti A; Fofi L; Altieri M; Giuliani G; Rainero I; Valente MR; Prudenzano MP; Merlo P; Boccalini A; Castro FL; Romozzi M; Calabresi P; Russo A; Volta GD; Albanese M; Trimboli M; Avino G; Vigani G; Munafò A; Cesaris F; Montisano DA; Grazzi L; Ornello R; Marcosano M; et alii...

SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study). in Cephalalgia : an international journal of headache / Cephalalgia. 2026 Jun;46(6):3331024261435922. doi: 10.1177/03331024261435922. Epub 2026 Jun 26.
2026
AOU Alessandria

Altamura C; Iannone LF; Castro FL; Sebastianelli G; Marcosano M; Santis F; Corrado M; Ornello R; Grazzi L; Montisano DA; Cesaris F; Munafò A; Avino G; Trimboli M; Albanese M; Russo A; Silvestro M; Volta GD; Romozzi M; Calabresi P; Boccalini A; Merlo P; Prudenzano MP; Valente MR; Rainero I; Giuliani G; Altieri M; Fofi L; Doretti A; et alii...

Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study. in CNS drugs / CNS Drugs. 2023 Dec;37(12):1069-1080. doi: 10.1007/s40263-023-01050-3. Epub 2023 Nov 24.
2023
AOU Alessandria

Caponnetto V; Russo A; Silvestro M; Tessitore A; De Icco R; Vaghi G; Sances G; Tassorelli C; Baraldi C; Castro FL; Guerzoni S; Prudenzano MP; Fallacara A; Gentile M; Ornello R; Onofri A; Burgalassi A; Chiarugi A; De Cesaris F; Granato A; Casalena A; De Tommaso M; Mampreso E; Merlo P; Coppola G; Battistini S; Rebecchi V; Rainero I; Sepe FN; et alii...